


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.32%
+11.38%
+1.19%
+1.36%
-2.73%
RMD
ResMed
$250.10
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value
Chart
$270.07 (-7.39%)
$284.89 (-12.21%)
$250.88 (-0.31%)
$243.68 (+2.63%)
RMD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

RMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
RMD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RMD Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is RMD current stock price?
What are RMD stock strengths?
What risks are associated with RMD stock?
When is RMD next earnings report?
What is RMD market cap and volume?
What is RMD's current Stock IQ?
Should I buy RMD stock right now?
Is RMD a Strong Buy right now?
What does a 'Strong Buy' rating mean for RMD?
What does a 'Strong Sell' rating mean for RMD?
What factors influence RMD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.32%
+11.38%
+1.19%
+1.36%
-2.73%
RMD
ResMed
Current Price
$250.10
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value

Chart
$270.07 (-7.39%)
$284.89 (-12.21%)
$250.88 (-0.31%)
$243.68 (+2.63%)
RMD Analysts Opinion
RMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
RMD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RMD Street Sentiment is extremely bullish and have positive views on the near-term outlook
RMD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
RMD Latest Analysis
Baird Maintains ResMed (RMD) Outperform Recommendation. Fintel reports that on November 3 2025 Baird maintained coverage of ResMed (NYSE:RMD) with a Outperform recommendation. Analyst Price Forecast Suggests 20.94% Upside
Tue Nov 4, 2025
These Analysts Revise Their Forecasts On ResMed Following Q1 Results. RMD) reported better-than-expected earnings for the first quarter on Thursday.The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.50 per share. The company reported quarterly sales of $1.336 billion which beat the analyst consensus estimate of $1.331 billion.“.Our fiscal year 2026 is off to a strong start with first-quarter performance reflecting continued progress towa
Fri Oct 31, 2025
ResMed declares $0.60 dividend.
Fri Oct 31, 2025
Resmed Stock Up on Q1 Earnings & Revenue Beat Margins Expand. RMDs Q1 earnings and revenues top estimates as solid device and mask sales lift margins and boost investor confidence.
Fri Oct 31, 2025
RMD Makes Notable Cross Below Critical Moving Average. In trading on Thursday shares of ResMed Inc. (Symbol: RMD) crossed below their 200 day moving average of $251.60 changing hands as low as $251.31 per share. ResMed Inc. shares are currently trading off about 0.8% on the day. The chart below shows the one year performance of
Thu Oct 30, 2025
Resmed Inc Q3 Profit Increases Beats Estimates . (RTTNews) - Resmed Inc (RMD.AX) announced a profit for its third quarter that Increased from last year and beat the Street estimates.
Thu Oct 30, 2025
ResMed (RMD) Q1 Earnings and Revenues Beat Estimates. ResMed (RMD) delivered earnings and revenue surprises of 2.41% and 0.94% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Thu Oct 30, 2025
Seeking Clues to ResMed (RMD) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics. Besides Wall Streets top-and-bottom-line estimates for ResMed (RMD) review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Wed Oct 29, 2025
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release. ResMed (RMD) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thu Oct 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.